Virological.org

Last updated
virological.org
Type of site
Discussion forum
Available inEnglish
FoundedNovember 2014
Owner Andrew Rambaut
URL virological.org
CommercialNo
RegistrationRequired for posting (invite-only)
LaunchedNovember 2014;9 years ago (2014-11)

Virological.org is a discussion forum for the pre-publication sharing and discussion of pathogenic virus sequence data. The forum was launched in November 2014 by Andrew Rambaut. [1] Scientists have often used the forum to publicly share the first available outbreak sequences, e.g. during the SARS-CoV-2 pandemic, [2] [3] [4] [5] [6] [7] [8] [9] the 2022–2023 mpox outbreak, and the Ebola virus epidemic in Guinea. [10]

Contents

Overview

Virological.org is used for rapid pre-publication dissemination [11] of public health related information by a community of virologists, phylogeneticists and epidemiologists. [12] [13] [14] [15]

See also

Related Research Articles

<span class="mw-page-title-main">Coronavirus</span> Subfamily of viruses in the family Coronaviridae

Coronaviruses are a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19, which is causing the ongoing pandemic. In cows and pigs they cause diarrhea, while in mice they cause hepatitis and encephalomyelitis.

<span class="mw-page-title-main">SARS-related coronavirus</span> Species of coronavirus causing SARS and COVID-19

Severe-acute-respiratory-syndrome–related coronavirus is a species of virus consisting of many known strains. Two strains of the virus have caused outbreaks of severe respiratory diseases in humans: severe acute respiratory syndrome coronavirus 1, which caused the 2002–2004 outbreak of severe acute respiratory syndrome (SARS), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is causing the ongoing pandemic of COVID-19. There are hundreds of other strains of SARSr-CoV, which are only known to infect non-human mammal species: bats are a major reservoir of many strains of SARSr-CoV; several strains have been identified in Himalayan palm civets, which were likely ancestors of SARS-CoV-1.

<span class="mw-page-title-main">SARS-CoV-1</span> Virus that causes SARS

Severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1), previously known as severe acute respiratory syndrome coronavirus (SARS-CoV), is a strain of coronavirus that causes severe acute respiratory syndrome (SARS), the respiratory illness responsible for the 2002–2004 SARS outbreak. It is an enveloped, positive-sense, single-stranded RNA virus that infects the epithelial cells within the lungs. The virus enters the host cell by binding to angiotensin-converting enzyme 2. It infects humans, bats, and palm civets. The SARS-CoV-1 outbreak was largely brought under control by simple public health measures. Testing people with symptoms, isolating and quarantining suspected cases, and restricting travel all had an effect. SARS-CoV-1 was most transmissible when patients were sick, so its spread could be effectively suppressed by isolating patients with symptoms.

<span class="mw-page-title-main">GISAID</span> Global initiative for sharing virus data

GISAID, the Global Initiative on Sharing All Influenza Data, previously the Global Initiative on Sharing Avian Influenza Data, is a global science initiative established in 2008 to provide access to genomic data of influenza viruses. The database was expanded to include the coronavirus responsible for the COVID-19 pandemic, as well as other pathogens. The database has been described as "the world's largest repository of COVID-19 sequences". GISAID facilitates genomic epidemiology and real-time surveillance to monitor the emergence of new COVID-19 viral strains across the planet.

Spillover infection, also known as pathogen spillover and spillover event, occurs when a reservoir population with a high pathogen prevalence comes into contact with a novel host population. The pathogen is transmitted from the reservoir population and may or may not be transmitted within the host population. Due to climate change and land use expansion, the risk of viral spillover is predicted to significantly increase.

Shi Zhengli is a Chinese virologist who researches SARS-like coronaviruses of bat origin. Shi directs the Center for Emerging Infectious Diseases at the Wuhan Institute of Virology (WIV). In 2017, Shi and her colleague Cui Jie discovered that the SARS coronavirus likely originated in a population of cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan. She came to prominence in the popular press as "Batwoman" during the COVID-19 pandemic for her work with bat coronaviruses. Shi was included in Time's 100 Most Influential People of 2020.

<span class="mw-page-title-main">SARS-CoV-2</span> Virus that causes COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

<span class="mw-page-title-main">Coronavirus diseases</span> List of Coronavirus diseases

Coronavirus diseases are caused by viruses in the coronavirus subfamily, a group of related RNA viruses that cause diseases in mammals and birds. In humans and birds, the group of viruses cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold, while more lethal varieties can cause SARS, MERS and COVID-19. As of 2021, 45 species are registered as coronaviruses, whilst 11 diseases have been identified, as listed below.

<span class="mw-page-title-main">Wuhan Institute of Virology</span> Research Institute in Wuhan, Hubei, China

The Wuhan Institute of Virology, Chinese Academy of Sciences is a research institute on virology administered by the Chinese Academy of Sciences (CAS), which reports to the State Council of the People's Republic of China. The institute is one of nine independent organisations in the Wuhan Branch of the CAS. Located in Jiangxia District, Wuhan, Hubei, it was founded in 1956 and opened mainland China's first biosafety level 4 (BSL-4) laboratory in 2018. The institute has collaborated with the Galveston National Laboratory in the United States, the Centre International de Recherche en Infectiologie in France, and the National Microbiology Laboratory in Canada. The institute has been an active premier research center for the study of coronaviruses.

Andrew Rambaut is a British evolutionary biologist, as of 2020 professor of molecular evolution at the University of Edinburgh.

<span class="mw-page-title-main">Saskia Popescu</span> Infectious disease epidemiologist

Saskia Popescu is an infectious disease epidemiologist and global health security expert in Phoenix, Arizona. She is an Assistant Professor of epidemiology at the University of Maryland, and holds academic appointments at the University of Arizona and George Mason University’s Schar School of Policy and Government, where she lectures on biopreparedness and outbreak response. Since the start of the Coronavirus disease 2019 pandemic, Popescu has worked to prepare for and mitigate the spread of the disease within healthcare and the entertainment industry, where she led the global epidemiology and infection prevention response for Netflix. She has been recognized for her communication efforts around the pandemic, as well as her work on the front lines in infection prevention and healthcare biopreparedness. Popescu currently is a Senior Fellow at the Council on Strategic Risks, addressing converging biological risks from biological weapons nonproliferation, biosecurity, emerging infectious diseases and ecological security, biopreparedness in private industry, and global health security vulnerabilities.

<span class="mw-page-title-main">COVID-19 Genomics UK Consortium</span> British genomics research consortium

The COVID-19 Genomics UK (COG-UK) consortium was a group of academic institutions and public health agencies in the United Kingdom created in April 2020 to collect, sequence and analyse genomes of SARS-CoV-2 at scale, as part of COVID-19 pandemic response.

<span class="mw-page-title-main">Variants of SARS-CoV-2</span> Notable variants of SARS-CoV-2

There are many variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Some are believed, or have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.

<span class="mw-page-title-main">Origin of COVID-19</span> Inquiries into the origins of SARS-CoV-2

Since the beginning of the COVID-19 pandemic, there have been efforts by scientists, governments, and others to determine the origin of the SARS-CoV-2 virus. Similar to other outbreaks, the virus derived from a bat-borne virus and most likely was transmitted to humans via another animal in nature or during wildlife trade such as that in food markets. While other explanations such as speculations that SARS-CoV-2 was accidentally released from a laboratory have been proposed, such explanations are not supported by evidence. Conspiracy theories about the virus's origin have also proliferated.

<span class="mw-page-title-main">COVID-19 lab leak theory</span> Proposed theory on the origins of COVID-19

The COVID-19 lab leak theory, or lab leak hypothesis, is the idea that SARS-CoV-2, the virus that caused the COVID-19 pandemic, came from a laboratory. This claim is highly controversial; most scientists believe the virus spilled into human populations through natural zoonosis, similar to the SARS-CoV-1 and MERS-CoV outbreaks, and consistent with other pandemics in human history. Available evidence suggests that the SARS-CoV-2 virus was originally harbored by bats, and spread to humans from infected wild animals, functioning as an intermediate host, at the Huanan Seafood Market in Wuhan, Hubei, China, in December 2019. Several candidate animal species have been identified as potential intermediate hosts. There is no evidence SARS-CoV-2 existed in any laboratory prior to the pandemic, or that any suspicious biosecurity incidents happened in any laboratory.

<span class="mw-page-title-main">SARS-CoV-2 Iota variant</span> Variant of the SARS-Cov-2 virus first identified in New York City

Iota variant, also known as lineage B.1.526, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in New York City in November 2020. The variant has appeared with two notable mutations: the E484K spike mutation, which may help the virus evade antibodies, and the S477N mutation, which helps the virus bind more tightly to human cells.

Jesse D. Bloom is an American computational virologist and Professor in the Basic Sciences Division, the Public Health Sciences Division, and the Herbold Computational Biology Program, at the Fred Hutchinson Cancer Center. He is also an Investigator of the Howard Hughes Medical Institute, and an Affiliate Professor in the University of Washington departments of Genome Sciences and Microbiology.

William Paul Duprex is a British scientist and advocate for vaccines and global health. He serves as Director of the University of Pittsburgh's Center for Vaccine Research and Regional Biocontainment Laboratory. Duprex holds the Jonas Salk Chair in Vaccine Research. He is also a professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine and serves as Editor-in-Chief of the Journal of General Virology, which is published by the Microbiology Society, and a senior editor of mSphere, published by the American Society for Microbiology. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. Duprex is a Fellow of the American Academy of Microbiology.

Anne Moscona is an American virologist and pediatrician. She is best known for identifying cell entry mechanisms for enveloped respiratory viruses, elucidating general infection mechanisms that apply to parainfluenza virus, Nipah virus, measles virus, and other viruses, and for applying this knowledge to identify antiviral strategies to prevent infection by viruses including SARS-CoV-2. She is frequently consulted as a medical expert during viral outbreaks, including epidemic and pandemic influenza. Since 2016, she has served as the Sherie L. Morrison Professor Microbiology & Immunology, Professor of Pediatrics, and Professor of Physiology & Cellular Biophysics at Columbia University Medical Center in New York City, where she directs the Center for Host Pathogen Interaction. In 2022, Moscona was elected as president of the American Society for Virology, the nation's leading virology research organization, and will lead the organization starting in July 2023. For the last two years she has served the American Society for Virology as Councilor for Medical Virology.

<span class="mw-page-title-main">Peter Bogner (businessman)</span> German-American businessman

Peter Bogner is a German-American former media executive who is the founder and current president of GISAID, a platform for rapid sharing of genomic sequences of emerging viruses, such as influenza and SARS-CoV-2.

References

  1. "Dispute simmers over who first shared SARS-CoV-2's genome". www.science.org. Retrieved 2023-06-14.
  2. "Chinese researchers reveal draft genome of virus implicated in Wuhan pneumonia outbreak". www.science.org. Retrieved 2023-06-14.
  3. "Twitter transformed science communication during the pandemic. Will it last?". www.science.org. Retrieved 2023-06-14.
  4. Kupferschmidt, Kai (2021-01-22). "New mutations raise specter of 'immune escape'". Science. 371 (6527): 329–330. Bibcode:2021Sci...371..329K. doi:10.1126/science.371.6527.329. ISSN   0036-8075. PMID   33479129. S2CID   231676882.
  5. "World on alert for potential spread of new SARS-like virus found in China". www.science.org. Retrieved 2023-06-14.
  6. "New coronavirus variants could cause more reinfections, require updated vaccines". www.science.org. Retrieved 2023-06-14.
  7. "Mining coronavirus genomes for clues to the outbreak's origins". www.science.org. Retrieved 2023-06-14.
  8. Zastrow, Mark (2020-04-24). "Open science takes on the coronavirus pandemic". Nature. 581 (7806): 109–110. Bibcode:2020Natur.581..109Z. doi:10.1038/d41586-020-01246-3. PMID   32332909. S2CID   256820452.
  9. PhD, Julianna LeMieux (2022-01-05). "Grudge Match against COVID-19 Enters Year Three". GEN - Genetic Engineering and Biotechnology News. Retrieved 2023-06-14.
  10. Kupferschmidt, Kai (2021-03-19). "Ebola virus may lurk in survivors for many years". Science. 371 (6535): 1188. Bibcode:2021Sci...371.1188K. doi:10.1126/science.371.6535.1188. ISSN   0036-8075. PMID   33737465. S2CID   232303082.
  11. "Rename monkeypox strains to remove geographic stigma, researchers say". www.science.org. Retrieved 2023-06-14.
  12. Burki, Talha (June 2023). "First shared SARS-CoV-2 genome: GISAID vs virological.org". The Lancet Microbe. 4 (6): e395. doi:10.1016/s2666-5247(23)00133-7. ISSN   2666-5247. PMC   10129129 . PMID   37116518.
  13. Molldrem, Stephen; Hussain, Mustafa I.; Smith, Anthony K J (2021-09-02). "Open science, COVID-19, and the news: Exploring controversies in the circulation of early SARS-CoV-2 genomic epidemiology research". Global Public Health. 16 (8–9): 1468–1481. doi:10.1080/17441692.2021.1896766. ISSN   1744-1692. PMC   8338786 . PMID   33661076.
  14. Ahuja, Anjana (2023-04-05). "We should learn from rival attempts to write pandemic history". Financial Times. Retrieved 2023-06-14.
  15. Yozwiak, Nathan L.; Schaffner, Stephen F.; Sabeti, Pardis C. (February 2015). "Data sharing: Make outbreak research open access". Nature. 518 (7540): 477–479. Bibcode:2015Natur.518..477Y. doi: 10.1038/518477a . ISSN   1476-4687. PMID   25719649.